
Opinion|Videos|September 6, 2024
Key Factors to Consider when Switching to Biosimilars
Author(s)Sophia Humphreys, PharmD, MHA
Dr Humphreys discusses key factors to consider when switching to biosimilars.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- To what extent should the pharmacy team prioritize supporting the switch from a reference product to a biosimilar, and what factors should be considered in making this decision?
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Overcoming Barriers to Kidney-Protective Therapy
2
What Pharmacists Should Know About Novo Nordisk–Eli Lilly GLP-1 Ad Suit
3
Overlooked Coronavirus Protein May Drive Cytokine Storm, Cardiac Injury in Severe COVID-19
4
Biosimilars: A Guide for Pharmacists
5






























































































